Investigating the effects of noise-induced hearing loss on serotonin transporters in rat brain using 4-[18F]-ADAM/small animal PET

NeuroImage

Volumn 75, Issue , 2013, Pages 262-269

  Kang, Hsiao Hsien ^a,b   Wang, Chih Hung ^b   Chen, Hsin Chien ^b   Li, I Hsun ^a,b   Cheng, Cheng Yi ^b   Liu, Ren Shyan ^c   Huang, Wen Sheng ^b,d   Shiue, Chyng Yann ^b   Ma, Kuo Hsing ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

4 18F ADAM; Immunohistochemistry; Noise induced hearing loss; Positron emission tomography; Serotonin transporter

Indexed keywords

N,N DIMETHYL 2 (2 AMINO 4 FLUOROPHENYLTHIO)BENZYLAMINE F 18; RADIOPHARMACEUTICAL AGENT; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; COCHLEA; CONTROLLED STUDY; EVOKED BRAIN STEM AUDITORY RESPONSE; HAIR CELL; HEARING IMPAIRMENT; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

ANIMALS; BENZYLAMINES; BRAIN; FLUORINE RADIOISOTOPES; HEARING LOSS, NOISE-INDUCED; IMMUNOHISTOCHEMISTRY; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84876446819     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.06.049     Document Type: Article

References (76)

1. Abi-Hachem R.N., Zine A., Van De Water T.R. The injured cochlea as a target for inflammatory processes, initiation of cell death pathways and application of related otoprotectives strategies. Recent Pat. CNS Drug Discov. 2010, 5:147-163.
2. 123I] ADAM and SPECT. J. Nucl. Med. 2001, 42:1556-1562.
3. Andersson G., McKenna L. Tinnitus masking and depression. Audiology 1998, 37:174-182.
4. Ask H., Krog N.H., Tambs K. Impact of hearing impairment on spousal mental health: the Nord-Trondelag Health Study. Eur. J. Public Health 2010, 20:271-275.
5. Belli S., Belli H., Bahcebasi T., Ozcetin A., Alpay E., Ertem U. Assessment of psychopathological aspects and psychiatric comorbidities in patients affected by tinnitus. Eur. Arch. Otorhinolaryngol. 2008, 265:279-285.
6. Bengel D., Johren O., Andrews A.M., Heils A., Mossner R., Sanvitto G.L., Saavedra J.M., Lesch K.P., Murphy D.L. Cellular localization and expression of the serotonin transporter in mouse brain. Brain Res. 1997, 778:338-345.
7. Bernabei V., Morini V., Moretti F., Marchiori A., Ferrari B., Dalmonte E., De Ronchi D., Rita Atti A. Vision and hearing impairments are associated with depressive-anxiety syndrome in Italian elderly. Aging Ment. Health 2011, 15:467-474.
8. Bonny C., Borsello T., Zine A. Targeting the JNK pathway as a therapeutic protective strategy for nervous system diseases. Rev. Neurosci. 2005, 16:57-67.
9. 123I] ADAM in healthy young adults. Nucl. Med. Biol. 2006, 33:185-191.
10. 18F]fluoromethyl)-(+)-McN5652. Neuropsychopharmacology 2003, 28:2010-2019.
11. 18F]-ADAM as an imaging agent for SERT in non-human primate brain using PET: a dynamic study. Nucl. Med. Biol. 2012, 39:279-285.
12. Cheng A.G., Cunningham L.L., Rubel E.W. Mechanisms of hair cell death and protection. Curr. Opin. Otolaryngol. Head Neck Surg. 2005, 13:343-348.
13. Chew H.S., Yeak S. Quality of life in patients with untreated age-related hearing loss. J. Laryngol. Otol. 2010, 124:835-841.
14. Chou Y.H., Wang S.J., Lin C.L., Mao W.C., Lee S.M., Liao M.H. Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study. Bipolar Disord. 2010, 12:312-318.
15. Clark M.S., McDevitt R.A., Hoplight B.J., Neumaier J.F. Chronic low dose ovine corticotropin releasing factor or urocortin II into the rostral dorsal raphe alters exploratory behavior and serotonergic gene expression in specific subregions of the dorsal raphe. Neuroscience 2007, 146:1888-1905.
16. Cransac H., Cottet-Emard J.M., Hellström S., Peyrin L. Specific sound-induced noradrenergic and serotonergic activation in central auditory structures. Hear. Res. 1998, 118:151-156.
17. Cruz O.L., Kasse C.A., Sanchez M., Barbosa F., Barros F.A. Serotonin reuptake inhibitors in auditory processing disorders in elderly patients: preliminary results. Laryngoscope 2004, 114:1656-1659.
18. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res. Brain Res. Rev. 1990, 15:71-100.
19. Frisina R.D. Age-related hearing loss: ear and brain mechanisms. Ann. N. Y. Acad. Sci. 2009, 1170:708-717.
20. Galiñanes G.L., Taravini I.R., Murer M.G. Dopamine-dependent periadolescent maturation of corticostriatal functional connectivity in mouse. J. Neurosci. 2009, 29:2496-2509.
21. 11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats. Synapse 2003, 47:123-133.
22. Glavaski-Joksimovic A., Virag T., Chang Q.A., West N.C., Mangatu T.A., McGrogan M.P., Dugich-Djordjevic M., Bohn M.C. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors. Cell Transplant. 2009, 18:801-814.
23. Graham C.E., Basappa J., Turcan S., Vetter D.E. The cochlear CRF signaling systems and their mechanisms of action in modulating cochlear sensitivity and protection against trauma. Mol. Neurobiol. 2011, 44:383-406.
24. Hartvig P., Bergström M., Antoni G., Långström B. Positron emission tomography and brain monoamine neurotransmission-entries for study of drug interactions. Curr. Pharm. Des. 2002, 8:1417-1434.
25. 123I-ADAM for the binding of serotonin transporters in the human brain. Psychiatry Res. 2011, 194:224-229.
26. Hu B.H., Zheng X.Y., McFadden S.L., Kopke R.D., Henderson D. R-phenylisopropyladenosine attenuates noise-induced hearing loss in the chinchilla. Hear. Res. 1997, 113:198-206.
27. Huang Q., Tang J. Age-related hearing loss or presbycusis. Eur. Arch. Otorhinolaryngol. 2010, 267:1179-1191.
28. 18F]-ADAM, a potent serotonin transporter imaging agent. Appl. Radiat. Isot. 2009, 67:1063-1067.
29. 123I-ADAM and small-animal SPECT. Nucl. Med. Commun. 2007, 28:615-621.
30. 11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys. J. Neurosci. 2006, 26:4638-4643.
31. Jarkas N., McConathy J., Votaw J.R., Voll R.J., Malveaux E., Camp V.M., Williams L., Goodman R.R., Kilts C.D., Goodman M.M. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography. Nucl. Med. Biol. 2005, 32:75-86.
32. 3 receptor. BMC Biol. 2004, 2:22.
33. Kalin N.H. Behavioral and endocrine studies of corticotropinreleasing hormone in primates. Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide 1990, 275-289. CRC Press, Inc., Boca Raton, FL. E.B. De Souza, C.B. Nemeroff (Eds.).
34. Kish S.J., Furukawa Y., Chang L.J., Tong J., Ginovart N., Wilson A., Houle S., Meyer J.H. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?. Nucl. Med. Biol. 2005, 32:123-128.
35. Koob G.F., Heinrichs S.C., Pich E.M., Menzaghi F., Baldwin H., Miczek K., Britton K.T. The role of corticotropin-releasing factor in behavioural responses to stress. Ciba Found. Symp. 1993, 172:277-289. (discussion 290-275).
36. Kotak V.C., Fujisawa S., Lee F.A., Karthikeyan O., Aoki C., Sanes D.H. Hearing loss raises excitability in the auditory cortex. J. Neurosci. 2005, 25:3908-3918.
37. Kotak V.C., Takesian A.E., Sanes D.H. Hearing loss prevents the maturation of GABAergic transmission in the auditory cortex. Cereb. Cortex 2008, 18:2098-2108.
38. Kvam M.H., Loeb M., Tambs K. Mental health in deaf adults: symptoms of anxiety and depression among hearing and deaf individuals. J. Deaf Stud. Deaf Educ. 2007, 12:1-7.
39. Lebrand C., Gaspar P., Nicolas D., Hornung J.P. Transitory uptake of serotonin in the developing sensory pathways of the common marmoset. J. Comp. Neurol. 2006, 499:677-689.
40. Li I.H., Huang W.S., Shiue C.Y., Huang Y.Y., Liu R.S., Chyueh S.C., Hu S.H., Liao M.H., Shen L.H., Liu J.C., Ma K.H. Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET. Neuroimage 2010, 49:1259-1270.
41. Li-Korotky H.S. Age-related hearing loss: quality of care for quality of life. Gerontologist 2012, 52:265-271.
42. Linthorst A.C., Flachskamm C., Hopkins S.J., Hoadley M.E., Labeur M.S., Holsboer F., Reul J.M. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge. J. Neurosci. 1997, 17:4448-4460.
43. 18F]-ADAM as a SERT imaging agent using micro-PET and autoradiography. Neuroimage 2009, 45:687-693.
44. Madruga C., Xavier L.L., Achaval M., Sanvitto G.L., Lucion A.B. Early handling, but not maternal separation, decreases emotional responses in two paradigms of fear without changes in mesolimbic dopamine. Behav. Brain Res. 2006, 166:241-246.
45. Marcusson J., Ross S. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets. Psychopharmacology 1990, 102:145-155.
46. Mausset-Bonnefont A.L., de Sèze R., Privat A. Immunohistochemistry as a tool for topographical semi-quantification of neurotransmitters in the brain. Brain Res. Brain Res. Protoc. 2003, 10:148-155.
47. Murphy D.L., Fox M.A., Timpano K.R., Moya P.R., Ren-Patterson R., Andrews A.M., Holmes A., Lesch K.-P., Wendland J.R. How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology 2008, 55:932-960.
48. Nielsen K., Brask D., Knudsen G.M., Aznar S. Immunodetection of the serotonin transporter protein is a more valid marker for serotonergic fibers than serotonin. Synapse 2006, 59:270-276.
49. Noristani H.N., Olabarria M., Verkhratsky A., Rodríguez J.J. Serotonin fibre sprouting and increase in serotonin transporter immunoreactivity in the CA1 area of hippocampus in a triple transgenic mouse model of Alzheimer's disease. Eur. J. Neurosci. 2010, 32:71-79.
50. Ohinata Y., Miller J.M., Schacht J. Protection from noise-induced lipid peroxidation and hair cell loss in the cochlea. Brain Res. 2003, 966:265-273.
51. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 1991, 43:425-473.
52. Papesh M.A., Hurley L.M. Plasticity of serotonergic innervation of the inferior colliculus in mice following acoustic trauma. Hear. Res. 2012, 283:89-97.
53. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2007, 6th ed.
54. Peng C.J., Huang Y.Y., Huang W.S., Shiue C.Y. An automated synthesis of N, N-dimethyl-2-(2-amino-4-[18F] fluorophenylthio) benzylamine (4-[18F]-ADAM) for imaging serotonin transporters. Appl. Radiat. Isot. 2008, 66:625-631.
55. Rao D., Basura G.J., Roche J., Daniels S., Mancilla J.G., Manis P.B. Hearing loss alters serotonergic modulation of intrinsic excitability in auditory cortex. J. Neurophysiol. 2010, 104:2693-2703.
56. Rasul A., El-Nour H., Blakely R.D., Lonne-Rahm S.B., Forsberg J., Johansson B., Theodorsson E., Nordlind K. Effect of chronic mild stress on serotonergic markers in the skin and brain of the NC/Nga atopic-like mouse strain. Arch. Dermatol. Res. 2011, 303:625-633.
57. Ravindran R., Rathinasamy S.D., Samson J., Senthilvelan M. Noise-stress-induced brain neurotransmitter changes and the effect of Ocimum sanctum (Linn) treatment in albino rats. J. Pharmacol. Sci. 2005, 98:354-360.
58. Remine M.D., Brown P.M. Comparison of the prevalence of mental health problems in deaf and hearing children and adolescents in Australia. Aust. N. Z. J. Psychiatry 2010, 44:351-357.
59. Shiue G.G., Choi S.R., Fang P., Hou C., Acton P.D., Cardi C., Saffer J.R., Greenberg J.H., Karp J.S., Kung H.F., Shiue C.Y. N, N-dimethyl-2-(2-amino-4-18F-fluorophenylthio)-benzylamine (4-18F-ADAM): an improved PET radioligand for serotonin transporters. J. Nucl. Med. 2003, 44:1890-1897.
60. Shiue G.G., Fang P., Shiue C.Y. Synthesis of N,N-dimethyl-2-(2-amino-4-[18F] fluorophenylthio)benzylamine as a serotonin transporter imaging agent. Appl. Radiat. Isot. 2003, 58:183-191.
61. Shoji F., Miller A.L., Mitchell A., Yamasoba T., Altschuler R.A., Miller J.M. Differential protective effects of neurotrophins in the attenuation of noise-induced hair cell loss. Hear. Res. 2000, 146:134-142.
62. Sinanović O., Brkić F., Salihović N., Junuzović L., Mrkonjić Z. Anxiety and depression in deaf and hard-of-hearing adults. Med. Arh. 2004, 58:87-90.
63. Sur C., Betz H., Schloss P. Immunocytochemical detection of the serotonin transporter in rat brain. Neuroscience 1996, 73:217-231.
64. B receptor: upregulated with age and hearing loss in mouse auditory system. Neurobiol. Aging 2007, 28:1112-1123.
65. Takeuchi Y., Sawada T., Blunt S., Jenner P., Marsden C.D. Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult rats. Brain Res. 1991, 562:301-305.
66. Tornabene S.V., Sato K., Pham L., Billings P., Keithley E.M. Immune cell recruitment following acoustic trauma. Hear. Res. 2006, 222:115-124.
67. Vicente-Torres M.A., Dávila D., Bartolomé M.V., Carricondo F., Gil-Loyzaga P. Biochemical evidence for the presence of serotonin transporters in the rat cochlea. Hear. Res. 2003, 182:43-47.
68. Wang J., Van De Water T.R., Bonny C., de Ribaupierre F., Puel J.L., Zine A. A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss. J. Neurosci. 2003, 23:8596-8607.
69. -/- female mice with hearing deficit affects social development of pups. PLoS One 2009, 4:e6508.
70. Wutzler A., Winter C., Kitzrow W., Uhl I., Wolf R.J., Heinz A., Juckel G. Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex. Neuropsychopharmacology 2008, 33:3176-3181.
71. Xu H., Kotak V.C., Sanes D.H. Conductive hearing loss disrupts synaptic and spike adaptation in developing auditory cortex. J. Neurosci. 2007, 27:9417-9426.
72. 123I] ADAM tracer. Comput. Methods Programs Biomed. 2008, 92:294-298.
73. 11C] SMe-ADAM, an imaging agent for the brain serotonin transporter: synthesis, pharmacological characterization and microPET studies in rats. Nucl. Med. Biol. 2006, 33:53-63.
74. Zhou F.C., Chiang Y.H., Wang Y. Constructing a new nigrostriatal pathway in the Parkinsonian model with bridged neural transplantation in substantia nigra. J. Neurosci. 1996, 16:6965-6974.
75. Zhou F.C., Tao-Cheng J.H., Segu L., Patel T., Wang Y. Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence. Brain Res. 1998, 805:241-254.
76. Zhou F.C., Lesch K.P., Murphy D.L. Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative. Brain Res. 2002, 942:109-119.